Black Diamond Therapeutics, Inc. (BDTX)
1.78
-0.08
(-4.30%)
USD |
NASDAQ |
Oct 30, 16:00
1.77
-0.01
(-0.56%)
After-Hours: 20:00
Black Diamond Therapeutics Total Assets (Quarterly) : 125.03M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 125.03M |
| March 31, 2026 | 132.92M |
| December 31, 2025 | 143.01M |
| September 30, 2025 | 157.73M |
| June 30, 2025 | 166.38M |
| March 31, 2025 | 176.24M |
| December 31, 2024 | 122.64M |
| September 30, 2024 | 137.90M |
| June 30, 2024 | 149.99M |
| March 31, 2024 | 142.52M |
| December 31, 2023 | 158.57M |
| September 30, 2023 | 172.38M |
| June 30, 2023 | 119.88M |
| March 31, 2023 | 135.58M |
| December 31, 2022 | 156.26M |
| September 30, 2022 | 180.42M |
| Date | Value |
|---|---|
| June 30, 2022 | 198.83M |
| March 31, 2022 | 219.48M |
| December 31, 2021 | 247.68M |
| September 30, 2021 | 274.13M |
| June 30, 2021 | 287.88M |
| March 31, 2021 | 313.26M |
| December 31, 2020 | 329.67M |
| September 30, 2020 | 346.44M |
| June 30, 2020 | 349.45M |
| March 31, 2020 | 362.80M |
| December 31, 2019 | 158.30M |
| September 30, 2019 | 80.73M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 51.83M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Lineage Cell Therapeutics, Inc. | 106.22M |
| Armata Pharmaceuticals, Inc. | 89.95M |
| Voyager Therapeutics, Inc. | 197.75M |
| Invivyd, Inc. | 218.88M |
| Elicio Therapeutics, Inc. | 31.33M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 28.94M |
| Shareholders Equity (Quarterly) | 96.09M |
| Debt to Equity Ratio | 0.1766 |
| Current Ratio | 7.284 |
| Net Debt Paydown Yield | 0.87% |